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Human immunodeficiency virus (HIV)-associated
nephropathy (HIVAN) is the most common finding on renal
biopsy in HIV-infected black patients and is also the
commonest cause of end-stage renal disease in these
patients. Early detection of HIVAN may be beneficial in
evaluating early treatment. This study examined the pattern
of renal diseases in HIV-infected South Africans and also
attempted to diagnose HIVAN at an early stage. In this
single-center cross-sectional study, 615 HIV-infected patients
were screened for proteinuria. Thirty patients with varying
degrees of proteinuria underwent renal biopsy. Patients with
diabetes mellitus, uncontrolled hypertension, known causes
of chronic kidney disease, and serum creatinine above
250 lmol/l were excluded. Patients in this study were not on
antiretroviral therapy. HIVAN was found in 25 (83%) patients.
Six of them (24%) had microalbuminuria. Altogether, seven
patients with persistent microalbuminuria were biopsied and
six (86%) showed HIVAN. Other biopsy findings included
membranoproliferative nephropathy in two (7%) and
interstitial nephritis in three (10%). Four patients with HIVAN
had associated membranous nephropathy. HIVAN is the
commonest biopsy finding among our study patients with
HIV infection who present with varying degrees of
proteinuria. Microalbuminuria is a manifestation of HIVAN
in our study patients. Therefore, microalbuminuria may be
an early marker of HIVAN, and screening for its presence may
be beneficial. Renal biopsy may be considered in seropositive
patients who present with persistent microalbuminuria,
especially with low CD4 counts irrespective of good renal
function. This will allow diagnosis and treatment of HIVAN at
an early stage and may prevent further disease progression.
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About 42 million people worldwide have been infected with
the human immunodeficiency virus (HIV).1 Almost 30
million HIV-infected people live in Africa, especially in
sub-Saharan Africa, which is the most affected region in the
world.2 Sub-Saharan Africa has just over 10% of the world’s
population, but is home to 60% of the world’s population
of those living with HIV, approximately 25.4 million people.
In South Africa, the estimate of HIV-1 prevalence from the
national population-based survey in adults aged 15–49 years
was about 16%,3 whereas the UNAIDS/WHO estimate based
on antenatal clinic data was 20.1%.4 It has the highest
number of people living with HIV in the world, estimated
at 5.3 million, with average life expectancy below the age of
40 years. HIV infection affects multiple organs and the
kidney is a common target. A variety of renal syndromes may
occur during the course of HIV infection.5 These can be
either acute or chronic. HIV-associated nephropathy
(HIVAN) is one of the chronic kidney diseases directly
caused by HIV infection.6 Black patients have a relative risk
of 51.1 for developing end-stage renal disease from AIDS or
an AIDS-defining diagnosis compared with white patients.7
HIVAN is reported as the commonest form of chronic renal
disease in HIV-infected patients and is the third leading cause
of end-stage renal disease in African Americans aged 20–64
in the United States.8–10 However, the actual incidence and
prevalence of renal diseases in HIV infection in general, and
that of HIVAN in particular, are unknown; this renders
epidemiologic assessments difficult. In Africa, there is also a
paucity of data regarding renal involvement in HIV disease.
The aim of this study, therefore, was to examine the pattern
of renal involvement in HIV-infected patients in South
Africa.
Early detection of HIVAN may be beneficial in evaluat-
ing early treatment in an attempt to protect the kidney
from further disease progression. This study, therefore, also
attempted to diagnose HIVAN at an early stage.
RESULTS
A total of 615 patients were screened between April 2002 and
April 2004. The characteristics of the patients are shown in
Table 1. Thirty-eight patients (6%) were found to have
proteinuria. Microalbuminuria was tested in 90 patients who
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agreed to participate further in the study and was present in
32 patients (36%). However, persistent microalbuminuria
was noted in only seven patients (8%). Of 45 patients (38 with
proteinuria and seven with persistent microalbuminuria),
only 30 patients underwent renal biopsy. Among the
proteinuric patients, 10 were lost to follow-up before the
renal biopsy was performed and five refused to have renal
biopsy; all seven patients with persistent microalbuminuria
agreed to the procedure. All were black Africans except for one
patient who was of mixed race of African origin as defined by
the registration office, based on the national identification
document. Of the 30 patients, 12 (40%) were male and 18
(60%) were female; mean age was 35 (range 17–43) years. The
mean CD4 count was 251/mm3 (range 3–641/mm3).
HIVAN was present in 25 (83%) patients, their mean CD4
count was 226/mm3 (range 3–586/mm3); six (24%) of these
patients had microalbuminuria (Table 2). The seven patients
with persistent microalbuminuria who underwent renal
biopsy had a mean CD4 count of 216/mm3 (range
114–379/mm3), mean serum creatinine of 66 mmol/l (range
37–111 mmol/l), and mean calculated creatinine clearance of
107 ml/min (estimated glomerular filtration rate of 133 ml/
min) (Table 3). The total number of glomeruli present in
biopsy samples from microalbuminuric patients varied from
11 to 45. One patient had interstitial inflammation without
glomerular or tubular alterations of HIVAN; this was inter-
preted as interstitial nephritis. One patient showed promi-
nent glomerular basement membrane with spikes and
electron-dense subepithelial deposits, indicating concomitant
membranous glomerulopathy in addition to features of
HIVAN. Detailed morphologic changes of microalbuminuric
patients are shown in Table 4. The representative images from
the microalbuminuric patients are illustrated in Figures 1–6.
Histological features of combined HIVAN and membranous
nephropathy (Figures 7a, b and 8) were found in four
patients, two of whom tested positive for HBsAg (Table 5);
the other two were tested negative for both HBsAg and
hepatitis B PCR. Anti-nuclear factor, hepatitis C virus
antibodies, and Wasserman reaction were negative in all four
patients. Other biopsy findings included two (7%) patients
with membranoproliferative glomerulonephritis and three
(10%) with interstitial nephritis (Table 6).
DISCUSSION
This study examined a population of HIV-infected subjects,
both in an in-patient, and an outpatient ambulatory setting.
Of the 615 patients, 15 (2%) were recruited when hospita-
lized for various reasons and 600 (98%) were asymptomatic
outpatients. We performed renal biopsies in 30 patients with
variable degrees of proteinuria, and HIVAN was the common-
est biopsy finding, present in 25 of 30 patients (83%). Almost
all patients presenting with persistent microalbuminuria who
underwent renal biopsy (six out of seven patients) showed the
presence of HIVAN. This particular patient group constituted
24% of all patients with HIVAN; they had a low mean CD4
count of 216/mm3 and normal renal function with a mean
calculated creatinine clearance of 107 ml/min (estimated
glomerular filtration rate of 133 ml/min).
Table 1 | Characteristics of patients evaluated for proteinuria
Characteristics Proteinuria negative
Microalbuminuric
UP 0.03–0.3 g/24 h
Macroalbuminuric
(proteinuric) UP40.3 g/24 h P-value
Demographics
Patients tested 615 90 615
Patients classified 570 7 38
Patients characterized 570 7 23
Age (years; mean (range)) 27 (13–63) 32 (21–40) 32 (17–55)
Sex: M/F 139/431 2/5 10/13
(%) (24/76) (29/71) (43/57)
Race
Black 559 (98%) 7 (100%) 22 (96%)
Indian 9 (1.6%) 0 0
White 2 (0.3%) 0 0
Mixed 0 0 1
Clinical
Systolic/diastolic BP (mmHg; mean7s.d.) 117714/7079 121715/81710 120712/74711
Peripheral edema (%) 0 0 61
CD4/mmł (mean7s.d.) 163735 216733 264746
UP (g/24 h; mean7s.d.) ND 0.1470.1 676 0.0138
Serum creatinine (mmol/l; mean7s.d.) 60 66722 125750 0.0071
eGFR (ml/min; mean7s.d.) ND 133731 77735 0.0009
HIVAN — 6 (86%) 19 (83%)
BP, blood pressure; eGFR, estimated glomerular filtration rate; F, female; HIVAN, HIV-associated nephropathy; M, male; ND, not done; s.d., standard deviation; UP, urine
protein.
Only significant P-values (in comparisons between micro- and macro-albuminuric groups) are shown.
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(lmol/l) Cr Cl (ml/min)
eGFR (ml/min/1.73 m2)
(MDRD equation) B C
Urine protein
(g/24 h)
1 29 F 3 77 88 99 () NA 0.94
2 28 F 183 69 80 113 () () 0.9
3 26 F 204 65 63 123 () NA 0.06
4 34 F 246 62 95 123 () () 0.30
5 40 M 199 111 78 82 () () 0.23
6 43 M 114 70 91 137 () () 0.04
7 27 F 379 58 104 140 () () 0.17
8 21 F 137 61 130 138 () () 0.07
9 26 M 586 90 117 114 () NA 6.33
10 17 F NA 82 48 102 () NA 2.9
11 43 M NA 213 39 38 () () 11.64
12 25 M 392 72 138 148 () () 1.14
13 24 F 335 112 49 66 () NA 3.61
14 38 M NA 161 55 54 () () 6.83
15 21 F 130 178 31 40 () () 9.21
16 38 F 159 181 45 35 (+) () 14.0
17 29 M 331 78 78 131 (+) () 24.75
18 55 M 402 103 89 92 () () 4.92
19 32 F 145 135 50 51 () () 5.75
20 29 F 145 172 56 39 () () 4.47
21 30 F 213 156 22 43 () NA 1.35
22 26 F NA 155 31 45 () NA 5.19
23 42 M 130 88 116 106 () () 2.23
24 29 M 90 119 104 89 () () 1.38
25 24 F NA 63 97 129 () () 11.15
Cr Cl, creatinine clearance; eGFR, estimated glomerular filtration rate; F, female; HIVN, HIV-associated nephropathy; M, male; MDRD, modification of diet in renal disease; NA,
not available; (), negative; (+), positive.
All were black Africans.







(lmol/l) Cr Cl (ml/min)
eGFR (ml/min/1.73 m2)
(MDRD equation) B C
Urine protein
(g/24 h) Renal biopsy
26 30 F 239 37 188 188 () () 0.13 IN
3 26 F 204 65 63 123 () NA 0.06 HIVAN
4 34 F 246 62 95 123 () () 0.30 HIVAN
5 40 M 199 111 78 82 () () 0.23 HIVAN
6 43 M 114 70 91 137 () () 0.04 HIVAN+Mem
GN
7 27 F 379 58 104 140 () () 0.17 HIVAN
8 21 F 137 61 130 138 () () 0.07 HIVAN
Cr Cl, creatinine clearance; eGFR, estimated glomerular filtration rate; HIVAN, HIV-associated nephropathy; IN, interstitial nephritis; MDRD, modification of diet in renal disease;
Mem GN, membranous glomerulonephritis; NA, not available; (), negative.
All were black Africans.
















26 28 0 (0) 0 0a 60 IN
3 11 5 (45) 5 25 40 HIVAN
4 11 6 (55) 3 30 30 HIVAN
5 17 5 (29) 5 30 10 HIVAN
6 45 8 (18) 8 25 10 HIVAN+Mem GNb
7 23 6 (26) 6 25 10 HIVAN
8 11 5 (45) 5 30 40 HIVAN
FSGS, focal segmental glomerulosclerosis; HIVAN, HIV-associated nephropathy; IN, interstitial nephritis; Mem GN, membranous glomerulonephritis.
a30% atrophic tubules present.
bAlso has prominent glomerular basement membrane with spikes+electron-dense subepithelial deposits.
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The prevalence of renal diseases associated with HIV
infection in Africa is unknown. There is a lack of surveillance
and reporting for renal disease in HIV-positive patients.
The true prevalence of HIVAN worldwide is also unclear.
Initial studies suggested that about 10% of HIV-infected
patients develop HIVAN.11–16 However, it appears that it is
influenced by the type of study (whether autopsy or biopsy-
based) and the demographics of the HIV-infected popula-
tion. The occurrence of HIVAN in autopsy studies of AIDS
patients varies from 1 to 12%.17–21 However, renal biopsy
series showed a higher prevalence of HIVAN when compared
with autopsy studies. We have reviewed the renal biopsy-
based studies (excluding autopsy series) reported in the
literature (Table 7). HIVAN was found to be the commonest
form of renal involvement in HIV-positive black patients,
Figure 1 | Microalbuminuric patient: low-power view
demonstrating dilated tubules (Hþ E, original
magnification,  120).
Figure 2 | Microalbuminuric patient: high-power view
demonstrating dilated tubules lined by flattened epithelium,
and containing pale eosinophilic luminal secretions (Hþ E,
original magnification,  480).
Figure 3 | Microalbuminuric patient: low-power view
demonstrating hypertrophied and dilated tubules (Hþ E,
original magnification,  120).
Figure 4 | Microalbuminuric patient: high-power view
demonstrating hypertrophied tubules lined by swollen
epithelial cells with vacuolated or eosinophilic cytoplasm
(Hþ E, original magnification,  480).
Figure 5 | Microalbuminuric patient: medium-power view
demonstrating collapsing glomerulopathy with focal segmental
glomerulonephritis (Hþ E, original magnification,  240).
Figure 6 | Microalbuminuric patient: focus of interstitial nephritis
containing interstitial lymphocytes and plasma cells with
associated tubular atrophy (Hþ E, original magnification,
 240).
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ranging from 53 to 79%,22–25 except for a study from the
Congo by Assounga et al.,26 who reported a lower rate
of HIVAN (19%) among black Africans; however, only 32
out of 43 HIV-positive patients underwent kidney biopsy.
The literature review by Bourgoignie27 of renal biopsies in
HIV-infected patients reported before 1990 revealed focal
segmental glomerulosclerosis in 83%. However, the racial or
ethnic origins of these patients were not mentioned in the
review, although it is likely that the majority were black.
The prevalence of HIVAN was variable among the different
racial groups. Casanova et al.28 conducted a biopsy study in
white Italian HIV-positive patients; however, HIVAN was not
demonstrated. The study by Praditpornsilpa et al.29 in Thailand
also did not demonstrate a single case of HIVAN among
26 HIV-positive patients presenting with varying degrees of
proteinuria. However, HIVAN was commonly found among
the HIV-infected black patients. Therefore, there may be a role
for genetic factors in the development of HIVAN.8–10
HIVAN was also found to occur in a high proportion
of our patients who were biopsied (83%). The patients
we recruited were hospital in-patients as well as asympto-
matic outpatients, which we consider to be fairly representa-
tive of the population we serve. Twelve of 25 patients with
HIVAN (48%) had nephrotic range proteinuria and most of
them were in-patients. However, outpatients with micro-
albuminuria were also included and that group, in fact,
constituted 24% of the total number of patients with HIVAN.
So this study covered both extremes of proteinuric patients,
from in- and outpatient groups.
Microalbuminuria has been assessed by various investiga-
tors to diagnose subclinical renal involvement in systemic
diseases. Valente et al.30 performed renal biopsies in patients
with systemic lupus erythematosus who had microalbumin-
uria but no clinical signs of renal involvement, to evaluate
subclinical lupus nephropathy. Fifteen (50%) had mesangial
glomerulonephritis type IIb, 12 (40%) had mesangial
glomerulonephritis type IIa, and three (10%) showed no
changes on light microscopy or immunofluorescence (IMF)
(type I). Similarly, microalbuminuric diabetic patients were
biopsied to detect the presence of diabetic nephropathy.
Typical diabetic nephropathy was found in a significant
number of patients.31,32 Studies also reported an association
between microalbuminuria and hypertension.33 According
to these reports, microalbuminuria appears to be an early
indicator of renal disease in patients with these systemic
Figure 7 | HIVAN combined with membranous
glomerulonephritis. (a) HIVAN (collapsing glomerulopathy) (arrow)
(Jones’ silver stain, original magnification,  240). (b) High-power
view of (a): membranous glomerulonephritis demonstrating spike
formation (arrow) (Jones’ silver stain,  1200, oil emersion).
Figure 8 | EM of Figure 7: ultrastructural examination
demonstrating thickened basement membrane with
subepithelial (black arrow) and intramembranous deposits
(white arrow), and swollen podocytes and foot process fusion
(bold arrow) (original magnification,  64 000).
Table 5 | Characteristics of patients with combined HIVAN and membranous nephropathy
Hepatitis serology
Patient no. Age (years) Sex CD4 Se Cr (lmol/l) Cr Cl (ml/min) UP (g/24 h) B C
6 43 M 114 70 91 0.04 () ()
16 38 F 159 181 45 14.0 (+) ()
17 29 M 331 78 78 24.75 (+) ()
25 24 F NA 63 97 11.15 () ()
All patients were black African.
Cr Cl, creatinine clearance; NA, not available; (), negative; (+), positive; Se Cr, serum creatinine; UP, urine protein.
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diseases. Therefore, microalbuminuria detected in HIV-
positive patients may be considered to be an early indicator
of the presence of subclinical renal disease that may be due to
HIVAN or other renal disease that is not due to HIV
nephropathy.
Luke et al.34 measured microalbuminuria in 72 HIV-
seropositive ambulatory patients. There were 14 patients
(19%) who had increased urinary microalbumin levels; seven
of these patients had proteinuria similar to those values
found in diabetic nephrotic syndrome. Two other studies
reported the prevalence of microalbuminuria, without
clinical evidence of renal disease, as 30 and 25%, respectively
in HIV-infected outpatients.35,36 However, renal biopsies
were not performed in these patients to determine the renal
pathology. There have been no renal biopsy studies under-
taken in HIV-infected patients with microalbuminuria to
date. In our study, seven patients with microalbuminuria
underwent renal biopsy and six (86%) patients had HIVAN.
Interestingly, the microalbuminuric group constituted 24%
of all patients with HIVAN. However, these patients had
normal renal function (mean calculated creatinine clearance
of 107 ml/min (estimated glomerular filtration rate of 133 ml/
min)) and had low CD4 counts (mean of 216 (range
114–379)). The majority of patients with HIVAN had low
CD4 counts (o250 in 12 out of 18 patients), in keeping with
other reports.23,37 Therefore, HIVAN occurs in patients with
low CD4 counts in general and can present initially with
microalbuminuria.
When comparing the characteristics of patients who were
evaluated for proteinuria, there were no significant differ-
ences in age, sex, race, mean blood pressure, and CD4 count
among the three different groups (Table 1). Subclinical renal
involvement in the proteinuria-negative group is not
excluded, as the majority were not tested for microalbumi-
nuria. As persistent microalbuminuria was found in 8% of
those whom we tested, it is likely that we would have detected
more patients with microalbuminuria, had they all been
tested. Subsequent renal biopsy, if carried out, may have
shown the renal abnormalities, as was the case in our study.
The finding of combined HIVAN and membranous
nephropathy in four patients is somewhat unusual. To our
knowledge, this combination has not been previously
reported in the literature. Two of these patients had positive
hepatitis B serology, which could explain the presence of









equation) (ml/min/1.73 m2) B C UP (g/24 h) Renal biopsy
26 30 B F 239 37 188/188 () () 0.13 IN
27 29 B M 641 198 48/45 () () 12.98 MPGN
28 34 B F 611 73 135/102 () NA 0.47 IN
29 42 MR M 210 147 25/58 () () 5.45 MPGN
30 40 B F 39 85 80/83 () () 0.48 IN
B, black; Cr Cl, creatinine clearance; eGFR, estimated glomerular filtration rate; F, female; IN, interstitial nephritis; M, male; MPGN, membranoproliferative glomerulonephritis;
MR, mixed race of African origin; NA, not available; (), negative; (+), positive.
Table 7 | Renal biopsy series
Study Country
Number of
patients biopsied HIVAN (%)
% African descent
with HIVAN Se Cr (lmol/l) UP (g/24 h) Mean CD4
Bourgoignie27 (1990) Literature review of
biopsies reported
before 1990
176 146 ? — — —
(83%)
Nochy et al.25 (1993) France 60 26 79% — — —
(29B+31C) (43%) (23/29)
Casanova et al.28 (1995) Italy 26 0 0% 61–735 0.2–17.6 —
(all white Italian) (0%)
Connolly et al.22 (1995) UK 19 11 73% 137–1400 2.6–10.0 208
(11B+7C+1A) (58%) (8/11) (o10–630)
Assounga et al.26 (1996) Congo 32 6 19% — — —
(all black African) (19%) (6/32)
Praditpornsilpa et al.29 (1999) Thailand 26 0 0% 53–2917 1.5–10.7 275
(all Asian) (0%) (o133 in 92%) (11–560)
Winston et al.23 (1999) USA 20 10 53% 123–495 1.1–12.0 60
(17AA+3H) (50%) (9/17) (o133 in 10%) (0–200)
Ahuja et al.24 1999) USA 14 9 75% 59–332 All 41.5 187
(12AA+2C) (64%) (9/12) (o133 in 44%) (6–686)
Our study South Africa 30 25 83% 61–213 0.04–24.75 232
(29B+1mixed
race)
(83%) (25/30) (o133 in 68%) (3–586)
A, Asian; AA, African American; B, black; C, caucasian; H, hispanic; HIVAN, HIV-associated nephropathy; Se Cr, serum creatinine; UP, urine protein.
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membranous nephropathy; however, the etiology in the
remaining two patients is unclear. HIV infection may be
the cause of both histological patterns, and needs further
clarification.
There were limitations to our study; the study design
involved a convenience sample rather than a random sample;
there were many more outpatients than in-patients; electron
microscopy (EM) and IMF studies could not be carried out
in most of the samples, which may have detected more cases
of membranous nephropathy, especially with EM, although
the diagnosis of HIVAN was obvious on light microscopy.
As HIV infection is a risk factor for the development of
chronic kidney disease, the recommendations of the HIV
Medicine Association of the Infectious Diseases Society of
America suggest screening for chronic kidney disease in
HIV-infected patients.38 The screening tests for kidney
disease in HIV-seropositive patients, in fact, should be consi-
dered similar to those carried out in patients with diabetes
mellitus, which includes testing for microalbuminuria, to
detect early renal involvement
In conclusion, microalbuminuria may be an early marker
of HIVAN and screening for its presence may be beneficial.
Renal biopsy may be considered in seropositive black patients
who present with persistent microalbuminuria, especially
with low CD4 counts irrespective of the level of renal
function. This will allow diagnosis and treatment of HIVAN
at an early stage and may prevent further progression of renal
disease.
MATERIALS AND METHODS
This is a single-center, cross-sectional study. Ethical approval for the
study was obtained from the Ethics Committee of the University
of KwaZulu-Natal. Patients attending HIV Clinic, referrals from
Medical OutPatient Departments, and hospital in-patients were
screened. Inclusion criteria were: (1) HIV seropositivity (detection
of HIV antibodies by enzyme-linked immunosorbent assay test and
confirmed by Western blot) and (2) proteinuria ranging from
microalbuminuria to severe proteinuria. Microalbuminuric patients
were also included in the study in order to detect HIVAN at an early
stage before macroalbuminuria developed. Standard urine dipstick
testing was by UriCheck 9 (RapiMed Diagnostics, Sekunjalo Health
Care, Sandton, South Africa) in all patients. Those with a positive
test for proteinuria proceeded to 24-h urine collection to quantify
the amount of protein in the urine. Those with normal dipstick tests
who agreed to further screening underwent further urinalysis for
microalbumin by Micral-Test strips (Roche, Laval, Quebe´c,
Canada). Patients with two positive tests for microalbumin at least
a month apart were selected as having persistent microalbuminuria
and were asked to collect 24-h urine for quantification of
microalbumin. Microalbuminuria was defined as the presence of
urinary protein between 30 and 300 mg/24 h. The confounding
factors for microalbuminuria such as fever, heavy exercise, cardiac
failure, hyperglycemia, uncontrolled hypertension, acute illness,
urinary tract infection, and prostatic disease had been looked for
and were excluded.
Exclusion criteria were (1) diabetes mellitus; (2) uncontrolled
hypertension (systolic blood pressure 4160 mmHg); (3) known
causes of chronic kidney disease such as chronic pyelonephritis,
autosomal dominant polycystic kidney disease, lupus nephritis and
(4) serum creatinine 4250 mmol/l. A cutoff serum creatinine level of
250 mmol/l was used to exclude those patients with advanced
nephropathy. All patients who met the inclusion criteria and agreed
to take part in the study underwent percutaneous renal biopsy
under ultrasound guidance after informed consent was obtained.
Biopsies were reported on by the Anatomical Pathology Depart-
ment. Light microscopy was carried out in all samples. The stains
included hematoxylin and eosin (Hþ E), periodic acid Schiff,
methanamine silver, Jones and Masson’s trichrome. Nine patients
had IMF studies carried out for immunoglobulin A, immunoglo-
bulin G, immunoglobulin M, complement C1q, C3, and C4. EM
was performed in six patients. The policy of the Department of
Anatomical Pathology initially was not to undertake IMF studies on
tissue samples from HIV-positive patients because of the possible
hazard to the laboratory staff. However, with a change in policy, IMF
studies were performed and nine subjects had IMF carried out.
There were some logistic problems with EM studies initially; an
attempt was made later to do EM and IMF studies in the remaining
tissue samples from the earlier biopsies. However, it was not possible
to retrieve more tissue for further studies, as all the wax blocks were
used up in the subjects initially studied.
All biopsy samples were reviewed by a single pathologist who was
blinded to the degree of proteinuria, but not to the HIV status of the
patients. HIVAN was defined as the presence of focal segmental
glomerulosclerosis, glomerular collapse, microcystic tubular dilata-
tion, and interstitial inflammation. Using a  10 objective, a
micrometer mounted on an HC PLAN  10/20 eyepiece was used to
quantify the tubular alterations. The tubular alterations were scored
by calculating the percentage involved in each core of tissue, in 100
sequential Hþ E-stained cores. This was then averaged to the closest
five. CD4 counts were measured by flow cytometry to assess the
stage of HIV disease. In terms of renal function, glomerular
filtration rate was estimated by using the Modification of Diet in
Renal Diseases equation and creatinine clearance was calculated,
based on 24-h urine samples and serum creatinine. Serological tests,
including anti-nuclear factor, Wasserman reaction, hepatitis B and
C, were carried out. As this study was undertaken before the free and
large-scale availability of antiretroviral therapy, the patients in this
study were not on antiretroviral therapy; none of the patients were
on angiotensin-converting enzyme inhibitors or angiotensin recep-
tor blockers at the time of renal biopsy. None of them had used
heroin or any illicit drugs in the past.
Statistical analysis
Results are expressed as mean7s.d. The significance of
differences among the groups was determined using analysis
of variance. The Bonferroni method was performed to
compare individual pairs of group means. Values of Po0.05
were considered significant.
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